Related Experiment Video

Updated: Aug 19, 2026

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells
09:05

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Embryonic stem cells: differentiation into cardiomyocytes and potential for heart repair and regeneration

Dinender Kumar1, Timothy J Kamp, Martin M LeWinter

  • 1Department of Medicine, University of Vermont, Burlington, VT, 05446, USA. Dinender.Kumar@uvm.edu

Coronary Artery Disease
|March 1, 2005
PubMed

Insights

Embryonic stem cells show promise for repairing heart damage. These cells can become heart muscle cells, offering potential for treating myocardial infarction and improving cardiac function after injury.

Area of Science:

  • Cardiovascular Research
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Heart disease often involves cardiomyocyte loss through apoptosis or necrosis.
  • Native cardiac repair capacity is insufficient, necessitating therapeutic interventions.
  • Cell transplantation is a promising strategy for myocardial repair.

Purpose of the Study:

  • To review the potential of embryonic stem (ES) cells for cardiomyocyte differentiation.
  • To assess the efficacy of ES cells in myocardial regeneration after infarction.
  • To evaluate ES cell-derived embryoid bodies (EBs) in vitro.

Main Methods:

  • Review of existing literature on ES cell differentiation and transplantation.
  • Analysis of studies using in vitro embryoid body models.
  • Examination of preclinical myocardial infarction models.

Main Results:

  • Embryonic stem cells can differentiate into cardiomyocytes in vitro within embryoid bodies.
  • Transplantation of ES cells has shown functional improvements in myocardial infarction models.
  • ES cell-derived therapies offer potential for myocardial regeneration.

Conclusions:

  • Embryonic stem cells hold significant potential for cardiac repair.
  • Further research is warranted to optimize ES cell-based therapies for heart disease.
  • ES cell differentiation and transplantation represent a viable therapeutic avenue for myocardial regeneration.

More Related Videos

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells08:00

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Published on: January 12, 2015

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...